Keyword Analysis & Research: cabotegravir

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
cabotegravir1.510.329944612

Keyword Research: People who searched cabotegravir also searched

Keyword CPC PCC Volume Score
cabotegravir0.520.7218425

Search Results related to cabotegravir on Search Engine

  • Cabotegravir - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Cabotegravir

    WebCabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection , as well as in an injectable combination with rilpivirine under the brand name Cabenuva.

    DA: 95 PA: 15 MOZ Rank: 38

  • Cabotegravir - Patient | NIH - Clinicalinfo

    hiv.gov

    https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-1/patient

    WebFeb 7, 2024 · When used for HIV treatment, cabotegravir is always used with the HIV medicine rilpivirine (brand name: Edurant). For short-term PrEP to reduce the risk of HIV infection in adults and adolescents who weigh at least 77 lb (35 kg), are HIV negative, and are at risk of getting HIV.

    DA: 47 PA: 52 MOZ Rank: 75

  • WHO recommends long-acting cabotegravir for HIV prevention

    who.int

    https://www.who.int/news/item/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention

    WebJul 28, 2022 · Русский. Español. WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of HIV infection.

    DA: 32 PA: 93 MOZ Rank: 76

  • FDA Approves First Injectable Treatment for HIV Pre-Exposure …

    fda.gov

    https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention

    WebDec 20, 2021 · Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77...

    DA: 43 PA: 67 MOZ Rank: 79

  • Cabotegravir Uses, Side Effects & Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/mtm/cabotegravir.html

    WebMay 23, 2022 · Drug class: Integrase strand transfer inhibitor. Medically reviewed by Drugs.com on May 23, 2022. Written by Cerner Multum. Uses. Side effects. Warnings. Before taking. Dosage. Interactions. What is cabotegravir? Cabotegravir is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.

    DA: 1 PA: 78 MOZ Rank: 89

  • Cabotegravir: MedlinePlus Drug Information

    medlineplus.gov

    https://medlineplus.gov/druginfo/meds/a621010.html

    WebCabotegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in the blood. Although cabotegravir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer.

    DA: 86 PA: 23 MOZ Rank: 11

  • Cabotegravir Apretude - Treatment - National HIV Curriculum

    uw.edu

    https://www.hiv.uw.edu/page/treatment/drugs/cabotegravir

    WebFeb 27, 2023 · 1. Indications and Usage. APRETUDE is indicated in at-risk adults and adolescents weighing at least 35 kg for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.

    DA: 2 PA: 83 MOZ Rank: 26

  • Cabotegravir (Oral Route) Proper Use - Mayo Clinic

    mayoclinic.org

    https://www.mayoclinic.org/drugs-supplements/cabotegravir-oral-route/proper-use/drg-20509570

    WebFor patients who will miss a monthly planned injection of Cabenuva: Adults and children 12 years of age and older weighing 35 kilograms (kg) or more—If you miss or plan to miss a scheduled monthly injection of Cabenuva by more than 7 days, take 30 milligrams (mg) in combination with 25 mg of rilpivirine once a day.

    DA: 55 PA: 8 MOZ Rank: 60

  • Cabotegravir: Side Effects, Interactions, Warnings and More.

    msn.com

    https://www.msn.com/en-us/health/drugs/in-cabotegravir/in-cabotegravir

    WebShake well before using. Use safe sex methods to prevent disease spread. Injected into muscle of buttock. Redness/pain/swelling may occur at injection site. Call Dr if appetite loss, clay color ...

    DA: 96 PA: 2 MOZ Rank: 91

  • Cabotegravir / Rilpivirine - Patient | NIH - Clinicalinfo

    hiv.gov

    https://clinicalinfo.hiv.gov/en/drugs/cabotegravir-rilpivirine/patient

    WebMar 8, 2024 · Cabotegravir / Rilpivirine. Drug Database: Cabotegravir / Rilpivirine. Search Drugs. Browse Drug Names A–Z. A. B. C. D. E. F. G. H. I. J. K. L. M. N. O. P. Q. R. S. T. U. V. W. X. Y. Z. # All. FDA Label: Kit. Drug information. Pronounce: Cabotegravir and Rilpivirine. Brand Name.

    DA: 60 PA: 69 MOZ Rank: 56